The Science Behind Aduhelm, a Controversial New Alzheimer’s Drug | WSJ

Описание к видео The Science Behind Aduhelm, a Controversial New Alzheimer’s Drug | WSJ

Biogen’s Aduhelm is the first approved treatment for early stage Alzheimer’s patients that may be able to slow the disease. WSJ explains how the drug interacts with brain cells, and why some doctors aren’t ready to prescribe it yet. Illustration: Jacob Reynolds

More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com
Visit the WSJ Video Center: https://wsj.com/video

On Facebook:   / videos  
On Twitter:   / wsj  
On Snapchat: https://on.wsj.com/2ratjSM

#Aduhelm #Alzheimers #WSJ

Комментарии

Информация по комментариям в разработке